Table 1. Association between CDCA5 expression in tumors from OSCC patients and their clinicopathological parameters.
| Parameter | Low CDCA5 (n=40) Number (%) | High CDCA5 (n=40) Number (%) | p value |
|---|---|---|---|
| Sex | |||
| Male | 23 (57.5) | 23 (57.5) | 1 |
| Female | 17 (42.5) | 17 (42.5) | |
| Primary tumor site | |||
| Tongue | 17 (42.5) | 14 (35) | 0.25 |
| Maxillary gingiva | 7 (17.5) | 5 (12.5) | |
| Mandibular gingiva | 9 (22.5) | 14 (35) | |
| Floor of mouth | 1 (2.5) | 4 (10) | |
| Buccal mucosa | 5 (12.5) | 3 (7.5) | |
| Lower lip | 1 (2.5) | 0 (0) | |
| Differentiation | |||
| Well | 33 (82.5) | 24 (60) | 0.05 |
| Moderate | 6 (15) | 10 (25) | |
| Poor | 1 (2.5) | 6 (15) | |
| TNM stage | |||
| Stage I, II | 24 (60) | 18 (45) | 0.262 |
| Stage III, IV | 16 (40) | 22 (55) | |
| Recurrence/Metastasis | |||
| No | 27 (67.5) | 18 (42.9) | 0.070 |
| Yes | 13 (32.5) | 22 (57.1) | |
| Local recurrence | 3 (7.5) | 10 (25) | 0.069 |
| Lymph node metastasis | 6 (15) | 7 (17.5) | 1 |
| Distant metastasis | 4 (10) | 5 (12.5) | 1 |